Blood cells, molecules & diseases · 2026
Clinical and molecular characterization of Hb Coimbra [HBB: c.300T>A p.(Asp100Glu)] in a three-generation Italian family: From diagnostic pitfalls to vascular risk.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pezzoli Francesco, Chiocca Elena, Tondo Annalisa, Fotzi Ilaria
Аннотация
BACKGROUND: High oxygen-affinity hemoglobin (HOAH) variants are rare causes of familial secondary erythrocytosis. Hb Coimbra [HBB: c.300T>A p.(Asp100Glu)] is a rare variant that can mimic β-thalassemia traits on HPLC, leading to diagnostic delays.
CASE PRESENTATION: We describe a three-generation Italian family affected by Hb Coimbra. The 5-year-old female proband presented with asymptomatic erythrocytosis (Hb 15.9 g/dL) and a spurious hemoglobin A2 (HbA2) peak of 39.6% on cation-exchange HPLC. Family screening revealed that her father was managed with erythroexchange (EEX), while her paternal grandfather suffered two ischemic strokes in the absence of traditional cardiovascular risk factors. Diagnosis was confirmed via DNA sequencing.
CONCLUSIONS: This case highlights the importance of recognizing pathognomonic HPLC artifacts to avoid misdiagnosis. It also underscores the need for long-term vascular risk stratification in pediatric carriers, particularly when a family history of thrombotic events is present.
CASE PRESENTATION: We describe a three-generation Italian family affected by Hb Coimbra. The 5-year-old female proband presented with asymptomatic erythrocytosis (Hb 15.9 g/dL) and a spurious hemoglobin A2 (HbA2) peak of 39.6% on cation-exchange HPLC. Family screening revealed that her father was managed with erythroexchange (EEX), while her paternal grandfather suffered two ischemic strokes in the absence of traditional cardiovascular risk factors. Diagnosis was confirmed via DNA sequencing.
CONCLUSIONS: This case highlights the importance of recognizing pathognomonic HPLC artifacts to avoid misdiagnosis. It also underscores the need for long-term vascular risk stratification in pediatric carriers, particularly when a family history of thrombotic events is present.